Corticosteroids With Vedolizumab in Crohn's Disease
Status:
Terminated
Trial end date:
2018-02-08
Target enrollment:
Participant gender:
Summary
Use of co-induction with corticosteroid therapies may accelerate the remission rate when used
with vedolizumab. Further, this may lead to higher rates of response and remission at week 10
than would be seen with vedolizumab monotherapy.